Details for Patent: 7,713,999
Summary for Patent: 7,713,999
| Title: | Thrombin receptor antagonists |
| Abstract: | Heterocyclic-substituted tricyclics of the formula or a pharmaceutically acceptable salt thereof, wherein: |
| Inventor(s): | Samuel Chackalamannil, Martin C. Clasby, William J. Greenlee, Yuguang Wang, Yan Xia, Enrico P. Veltri, Mariappan V. Chelliah |
| Assignee: | Deerfield Management Company Lp As Administrative Agent , Xspire Pharma LLC |
| Application Number: | US11/733,635 |
|
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 7,713,999
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,713,999
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 1495018 | ⤷ Start Trial | C300746 | Netherlands | ⤷ Start Trial |
| European Patent Office | 1495018 | ⤷ Start Trial | CA 2015 00037 | Denmark | ⤷ Start Trial |
| European Patent Office | 1495018 | ⤷ Start Trial | PA2015027 | Lithuania | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
